Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19

A. Kulkarni, Pramod Kumar, H. Tevethia, M. Premkumar, J. P. Arab, R. Candia, R. Talukdar, Mithun Sharma, X. Qi, P. N. Rao, D. Reddy

Alimentary pharmacology & therapeutics, 2020

The incidence of elevated liver chemistries and the presence of pre‐existing chronic liver disease (CLD) have been variably reported in COVID‐19.

Cited by 62 publications.

Field of study: Medicine

10.1111/apt.15916